Novo Nordisk's Rybelsus gets US FDA approval for CV risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event ...
Gedatolisib combined with fulvestrant, with or without palbociclib, significantly improved PFS in HR-positive, HER2-negative, PIK3CA wild-type advanced breast cancer. The triplet regimen reduced ...
Health on MSN
4 Best Foods for Pancreatitis—Plus Foods To Avoid
Pancreatitis can cause nutrient deficiencies. A well-balanced diet can help relieve symptoms such as inflammation and pain, ...
The National on MSN
Weight-loss surgery helps more than half of UAE patients beat diabetes, study finds
More than half of patients in the UAE with type 2 diabetes who undergo bariatric surgery achieve complete remission from ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...
The Roanoke City Health Department will present data showing that the average Roanoker isn’t as healthy as an average Virginian, on multiple measures.
Talking With Docs on MSN
Myths about diabetes debunked
‘No drinking, no drugs, no smoking’: Eric Trump opens up about growing up in the Trump household Bruce Springsteen's Only ...
News-Medical.Net on MSN
MRI age clocks reveal how each organ ages differently and predict who develops disease or lives longer
Researchers developed seven MRI-based biological age clocks across major organs using UK Biobank imaging, linking each to ...
The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback